Search research articles
Contact Us
Filters
Showing results (31-40 of 111) with videos related to
Page
of 12
Sort By:
Archives of Neurology
|
November 1, 1986
Magnetic resonance imaging. Clinical correlation in 64 patients with multiple sclerosis
J C Stevens, M R Farlow, M K Edwards, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
October 9, 2001
Assessment of dietary therapies in a canine model of Batten disease
A N Siakotos, G D Hutchins, M R Farlow, et al.
Acta Neurologica Scandinavica. Supplementum
|
March 29, 2001
Cholinesterase inhibitors, beta-amyloid precursor protein and amyloid beta-peptides in Alzheimer's disease
D K Lahiri, M R Farlow, N Hintz, et al.
Archives of Neurology
|
January 27, 1998
Functional brain imaging in apraxia
D A Kareken, F Unverzagt, K Caldemeyer, et al.
Annals of Neurology
|
April 18, 1998
Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism
A Brashear, I J Butler, K Hyland, et al.
Archives of Neurology
|
March 20, 2001
Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression
M R Farlow, A Hake, J Messina, et al.
Neuroscience
|
February 15, 2005
Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation
X Wei, L Zhao, J Liu, et al.
Archives of Neurology
|
June 27, 2000
Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene
J R Murrell, A M Hake, K A Quaid, et al.
Neuroscience Letters
|
November 17, 2001
Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons
S Lin, Y Zhang, R Dodel, et al.
Journal of Genetic Counseling
|
July 5, 2015
Presymptomatic Genetic Testing with an APP Mutation in Early-Onset Alzheimer Disease: A Descriptive Study of Sibship Dynamics
K A Quaid, J R Murrell, A M Hake, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 111) with videos related to
Sort By:
Page
of 12
Archives of Neurology
|
November 1, 1986
Magnetic resonance imaging. Clinical correlation in 64 patients with multiple sclerosis
J C Stevens, M R Farlow, M K Edwards, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
October 9, 2001
Assessment of dietary therapies in a canine model of Batten disease
A N Siakotos, G D Hutchins, M R Farlow, et al.
Acta Neurologica Scandinavica. Supplementum
|
March 29, 2001
Cholinesterase inhibitors, beta-amyloid precursor protein and amyloid beta-peptides in Alzheimer's disease
D K Lahiri, M R Farlow, N Hintz, et al.
Archives of Neurology
|
January 27, 1998
Functional brain imaging in apraxia
D A Kareken, F Unverzagt, K Caldemeyer, et al.
Annals of Neurology
|
April 18, 1998
Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism
A Brashear, I J Butler, K Hyland, et al.
Archives of Neurology
|
March 20, 2001
Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression
M R Farlow, A Hake, J Messina, et al.
Neuroscience
|
February 15, 2005
Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation
X Wei, L Zhao, J Liu, et al.
Archives of Neurology
|
June 27, 2000
Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene
J R Murrell, A M Hake, K A Quaid, et al.
Neuroscience Letters
|
November 17, 2001
Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons
S Lin, Y Zhang, R Dodel, et al.
Journal of Genetic Counseling
|
July 5, 2015
Presymptomatic Genetic Testing with an APP Mutation in Early-Onset Alzheimer Disease: A Descriptive Study of Sibship Dynamics
K A Quaid, J R Murrell, A M Hake, et al.
Page
of 12